EUVIMEDEUVIMED entdecken
Crossref

Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey

Sarah Lee iD, Adrienne Conza, Itohan Aigbekaen, Jasmine Chang, Yasin Damji

Pediatric Dermatology · 20.07.2026

DOI: 10.1111/pde.70316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 20.07.2026. Verfasst von Sarah Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral Janus kinase inhibitors (JAKi) are increasingly used for pediatric and young adult alopecia areata (AA), yet patient‐reported satisfaction and perspectives on benefit–risk tradeoffs remain limited. Patients ≤ 25 years with physician‐diagnosed AA receiving oral JAKi at a tertiary pediatric dermatology center were surveyed, assessing treatment satisfaction, perceived disease and hair loss severity, continuation decisions under explicit risk framings, and free‐text experiences. Among 25 respondents, satisfaction was high, self‐rated hair loss severity decreased from treatment initiation to survey completion, and most participants intended to continue therapy despite framing of potential risks such as growth impairments or serious adverse events. Qualitative responses emphasized hair regrowth, good tolerability, and improvements in quality of life and mental health, highlighting outcomes central to shared decision‐making.

Schlagwörter

Stichwörter der Autor:innen

alopecia areatajanus kinase inhibitorspatient satisfactionpediatricsquality of life

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts, USA.
  • UMass Chan Medical School, Worcester, Massachusetts, USA.
  • Dermatology Section, Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Sarah Lee

Zitieren

APA

Lee, S., Conza, A., Aigbekaen, I., Chang, J., & Damji, Y. (2026). Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey. Pediatric Dermatology. https://doi.org/10.1111/pde.70316

Vancouver

Lee S, Conza A, Aigbekaen I, Chang J, Damji Y. Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey. Pediatric Dermatology. 2026. doi:10.1111/pde.70316

BibTeX
@article{Lee2026,
  author = {Lee, Sarah and Conza, Adrienne and Aigbekaen, Itohan and Chang, Jasmine and Damji, Yasin},
  title = {Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey},
  journal = {Pediatric Dermatology},
  year = {2026},
  doi = {10.1111/pde.70316}
}
Kostenlos starten →